SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
11-Mar-24 4:43 PM View: | Outlook Therapeutics, Inc. (OTLK) | 07-Mar-24 | Private Purchase | 62,484 | $0.42 | $26,243.30 | 8% 745.98K to 808.46K | |
24-Jan-23 8:08 PM View: | Outlook Therapeutics, Inc. (OTLK) | 20-Jan-23 | Sale | 267,000 | $1.11 | $296,370.00 | (26%) 1.01M to 745.98K | |
19-Jan-23 8:05 PM View: | Outlook Therapeutics, Inc. (OTLK) | 19-Jan-23 | Sale | 103,255 | $1.22 | $125,971.00 | (9%) 1.12M to 1.01M | |
19-Jan-23 8:05 PM View: | Outlook Therapeutics, Inc. (OTLK) | 18-Jan-23 | Sale | 33,738 | $1.25 | $42,172.50 | (3%) 1.15M to 1.12M | |
19-Jan-23 8:05 PM View: | Outlook Therapeutics, Inc. (OTLK) | 17-Jan-23 | Sale | 27,162 | $1.31 | $35,582.20 | (2%) 1.18M to 1.15M | |
06-Dec-21 5:25 PM View: | Outlook Therapeutics, Inc. (OTLK) | 03-Dec-21 | Private Purchase | 35,200 | $1.34 | $47,168.00 | 3% 1.14M to 1.18M | |
25-Feb-21 8:52 PM View: | Outlook Therapeutics, Inc. (OTLK) | 23-Feb-21 | Market Sale | 8,554 | $2.09 | $17,860.80 | (< 1%) 1.15M to 1.14M | (10%) |
17-Feb-21 9:14 PM View: | Outlook Therapeutics, Inc. (OTLK) | 12-Feb-21 | Market Sale | 56,973 | $2.55 | $145,281.00 | (5%) 1.21M to 1.15M | (8%) |
21-Apr-20 6:41 PM View: | Outlook Therapeutics, Inc. (OTLK) | 19-Mar-20 | Grant | 1,207,460 | -- | -- | 100% 0 to 1.21M |